Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Identification of Differential Roles of MicroRNA-33a and -33b During Atherosclerosis Progression With Genetically Modified Mice.

Koyama S, Horie T, Nishino T, Baba O, Sowa N, Miyasaka Y, Kuwabara Y, Nakao T, Nishiga M, Nishi H, Nakashima Y, Nakazeki F, Ide Y, Kimura M, Tsuji S, Ruiz Rodriguez R, Xu S, Yamasaki T, Otani C, Watanabe T, Nakamura T, Hasegawa K, Kimura T, Ono K.

J Am Heart Assoc. 2019 Jul 2;8(13):e012609. doi: 10.1161/JAHA.119.012609. Epub 2019 Jun 27.

2.

An in Vivo miRNA Delivery System for Restoring Infarcted Myocardium.

Yang H, Qin X, Wang H, Zhao X, Liu Y, Wo HT, Liu C, Nishiga M, Chen H, Ge J, Sayed N, Abilez OJ, Ding D, Heilshorn SC, Li K.

ACS Nano. 2019 Sep 24;13(9):9880-9894. doi: 10.1021/acsnano.9b03343. Epub 2019 Jun 7.

PMID:
31149806
3.

MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons.

Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, Baba O, Kuwabara Y, Nishino T, Nakao T, Nishiga M, Nishi H, Nakashima Y, Ide Y, Koyama S, Kimura M, Tsuji S, Naitoh M, Suzuki S, Izumi Y, Kawarai T, Kaji R, Kimura T, Inoue H, Ono K.

Clin Sci (Lond). 2019 Feb 22;133(4):583-595. doi: 10.1042/CS20180980. Print 2019 Feb 28.

PMID:
30777884
4.

Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction.

Hakuno D, Kimura M, Ito S, Satoh J, Nakashima Y, Horie T, Kuwabara Y, Nishiga M, Ide Y, Baba O, Nishi H, Nakao T, Nishino T, Nakazeki F, Koyama S, Hanada R, Randolph RR, Endo J, Kimura T, Ono K.

Sci Rep. 2018 Nov 13;8(1):16749. doi: 10.1038/s41598-018-35194-w.

5.

SREBF1/MicroRNA-33b Axis Exhibits Potent Effect on Unstable Atherosclerotic Plaque Formation In Vivo.

Nishino T, Horie T, Baba O, Sowa N, Hanada R, Kuwabara Y, Nakao T, Nishiga M, Nishi H, Nakashima Y, Nakazeki F, Ide Y, Koyama S, Kimura M, Nagata M, Yoshida K, Takagi Y, Nakamura T, Hasegawa K, Miyamoto S, Kimura T, Ono K.

Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2460-2473. doi: 10.1161/ATVBAHA.118.311409.

PMID:
30354203
6.

Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.

Nagao K, Inada T, Tamura A, Kajitani K, Shimamura K, Yukawa H, Aida K, Sowa N, Nishiga M, Horie T, Makita T, Ono K, Tanaka M.

ESC Heart Fail. 2018 Dec;5(6):1044-1051. doi: 10.1002/ehf2.12360. Epub 2018 Oct 1.

7.

Loss of periostin ameliorates adipose tissue inflammation and fibrosis in vivo.

Nakazeki F, Nishiga M, Horie T, Nishi H, Nakashima Y, Baba O, Kuwabara Y, Nishino T, Nakao T, Ide Y, Koyama S, Kimura M, Tsuji S, Sowa N, Yoshida S, Conway SJ, Yanagita M, Kimura T, Ono K.

Sci Rep. 2018 Jun 4;8(1):8553. doi: 10.1038/s41598-018-27009-9.

8.

MicroRNA 33 Regulates the Population of Peripheral Inflammatory Ly6Chigh Monocytes through Dual Pathways.

Baba O, Horie T, Nakao T, Hakuno D, Nakashima Y, Nishi H, Kuwabara Y, Nishiga M, Nishino T, Ide Y, Nakazeki F, Koyama S, Kimura M, Hanada R, Kawahara M, Kimura T, Ono K.

Mol Cell Biol. 2018 Jun 28;38(14). pii: e00604-17. doi: 10.1128/MCB.00604-17. Print 2018 Jul 15.

9.

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles.

Nishiga M, Guo H, Wu JC.

Eur Heart J. 2018 May 21;39(20):1848-1850. doi: 10.1093/eurheartj/ehy097. No abstract available.

10.

Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways.

Nakao T, Horie T, Baba O, Nishiga M, Nishino T, Izuhara M, Kuwabara Y, Nishi H, Usami S, Nakazeki F, Ide Y, Koyama S, Kimura M, Sowa N, Ohno S, Aoki H, Hasegawa K, Sakamoto K, Minatoya K, Kimura T, Ono K.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2161-2170. doi: 10.1161/ATVBAHA.117.309768. Epub 2017 Sep 7.

PMID:
28882868
11.

Dynamic changes of serum microRNA-122-5p through therapeutic courses indicates amelioration of acute liver injury accompanied by acute cardiac decompensation.

Koyama S, Kuragaichi T, Sato Y, Kuwabara Y, Usami S, Horie T, Baba O, Hakuno D, Nakashima Y, Nishino T, Nishiga M, Nakao T, Arai H, Kimura T, Ono K.

ESC Heart Fail. 2017 May;4(2):112-121. doi: 10.1002/ehf2.12123. Epub 2016 Dec 1.

12.

Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model.

Izuhara M, Kuwabara Y, Saito N, Yamamoto E, Hakuno D, Nakashima Y, Horie T, Baba O, Nishiga M, Nakao T, Nishino T, Nakazeki F, Ide Y, Kimura M, Kimura T, Ono K.

PLoS One. 2017 Mar 2;12(3):e0172798. doi: 10.1371/journal.pone.0172798. eCollection 2017.

13.

MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol.

Nishiga M, Horie T, Kuwabara Y, Nagao K, Baba O, Nakao T, Nishino T, Hakuno D, Nakashima Y, Nishi H, Nakazeki F, Ide Y, Koyama S, Kimura M, Hanada R, Nakamura T, Inada T, Hasegawa K, Conway SJ, Kita T, Kimura T, Ono K.

Circ Res. 2017 Mar 3;120(5):835-847. doi: 10.1161/CIRCRESAHA.116.309528. Epub 2016 Dec 5.

PMID:
27920122
14.

Predictors of Rapid Progression and Clinical Outcome of Asymptomatic Severe Aortic Stenosis.

Nishimura S, Izumi C, Nishiga M, Amano M, Imamura S, Onishi N, Tamaki Y, Enomoto S, Miyake M, Tamura T, Kondo H, Kaitani K, Nakagawa Y.

Circ J. 2016 Jul 25;80(8):1863-9. doi: 10.1253/circj.CJ-16-0333. Epub 2016 Jun 21.

15.

Prognostic Significance of ST-Segment Elevation in Leads V₁-₂ in Patients With Severe Aortic Stenosis.

Taniguchi T, Shiomi H, Kosuge M, Morimoto T, Nakatsuma K, Nishiga M, Sasa T, Saito N, Kimura T.

Circ J. 2016;80(2):526-34. doi: 10.1253/circj.CJ-15-0641. Epub 2016 Jan 8.

16.

Expression Patterns of miRNA-423-5p in the Serum and Pericardial Fluid in Patients Undergoing Cardiac Surgery.

Miyamoto S, Usami S, Kuwabara Y, Horie T, Baba O, Hakuno D, Nakashima Y, Nishiga M, Izuhara M, Nakao T, Nishino T, Ide Y, Nakazeki F, Wang J, Ueyama K, Kimura T, Ono K.

PLoS One. 2015 Nov 12;10(11):e0142904. doi: 10.1371/journal.pone.0142904. eCollection 2015.

17.

MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.

Kuwabara Y, Horie T, Baba O, Watanabe S, Nishiga M, Usami S, Izuhara M, Nakao T, Nishino T, Otsu K, Kita T, Kimura T, Ono K.

Circ Res. 2015 Jan 16;116(2):279-88. doi: 10.1161/CIRCRESAHA.116.304707. Epub 2014 Oct 31.

PMID:
25362209
18.

MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo.

Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Nakazeki F, Ide Y, Koyama S, Sowa N, Yahagi N, Shimano H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K.

Sci Rep. 2014 Jun 16;4:5312. doi: 10.1038/srep05312.

19.

Acute myocardial infarction and 30-year coronary aneurysm follow-up by serial angiography in a young adult with Kawasaki disease.

Matsushita K, Tamura T, Nishiga M, Kaitani K, Izumi C, Nakagawa Y.

Cardiovasc Interv Ther. 2015 Apr;30(2):142-6. doi: 10.1007/s12928-014-0262-8. Epub 2014 Apr 12.

PMID:
24729026
20.

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.

Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa N, Yahagi N, Shimano H, Matsumura S, Inoue K, Marusawa H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K.

Nat Commun. 2013;4:2883. doi: 10.1038/ncomms3883.

21.

Experimental chemonucleolysis with recombinant human matrix metalloproteinase 7 in human herniated discs and dogs.

Haro H, Nishiga M, Ishii D, Shimomoto T, Kato T, Takenouchi O, Koyanagi S, Ohba T, Komori H.

Spine J. 2014 Jul 1;14(7):1280-90. doi: 10.1016/j.spinee.2013.11.039. Epub 2013 Dec 1.

PMID:
24295797
22.

Effects of medical treatment on the prognosis and risk of embolic events in patients with severe aortic plaque.

Nishiga M, Izumi C, Matsutani H, Hashiwada S, Takahashi S, Hayama Y, Nakajima S, Sakamoto J, Hanazawa K, Miyake M, Tamura T, Kondo H, Motooka M, Kaitani K, Nakagawa Y.

J Atheroscler Thromb. 2013;20(11):821-9. Epub 2013 Aug 15.

23.

A case of significantly increased mitral regurgitation early after atrial septal defect closure.

Nishiga M, Izumi C, Matsutani H, Hashiwada S, Takahashi S, Hayama Y, Nakajima S, Sakamoto J, Hanazawa K, Miyake M, Tamura T, Kondo H, Motooka M, Kaitani K, Nakagawa Y.

J Echocardiogr. 2012 Jun;10(2):69-71. doi: 10.1007/s12574-012-0123-3. Epub 2012 Apr 19.

PMID:
27278048
24.

Progression of isolated tricuspid regurgitation late after left-sided valve surgery. Clinical features and mechanisms.

Izumi C, Miyake M, Takahashi S, Matsutani H, Hashiwada S, Kuwano K, Hayashi H, Nakajima S, Nishiga M, Hanazawa K, Sakamoto J, Kondo H, Tamura T, Kaitani K, Yamanaka K, Nakagawa Y.

Circ J. 2011;75(12):2902-7. Epub 2011 Sep 23.

25.

Marked regression of aortic plaque by intensive cholesterol-lowering therapy.

Sakamoto J, Izumi C, Takahashi S, Hashiwada S, Nakajima S, Nishiga M, Yamao K, Hanazawa K, Miyake M, Tamura T, Kondo H, Motooka M, Kaitani K, Nakagawa Y.

J Atheroscler Thromb. 2011;18(5):421-4. Epub 2011 Jan 13.

26.

Cardiac tamponade during transesophageal echocardiography in a patient with infective endocarditis.

Miyake M, Izumi C, Kuwano K, Honjo G, Matsutani H, Hashiwada S, Takahashi S, Nishiga M, Nakajima S, Yamao K, Hanazawa K, Sakamoto J, Yoshitani K, Motooka M, Kaitani K, Izumi T, Kobashi Y, Nakagawa Y.

J Echocardiogr. 2010 Mar;8(1):25-7. doi: 10.1007/s12574-009-0023-3. Epub 2009 Oct 2.

PMID:
27278541
27.

[Participation of endogenous brain histamine on learning and memory].

Masuoka T, Nishiga M, Chen Z, Kamei C.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2006 Aug;26(4):141-8. Review. Japanese.

PMID:
17020130
28.

Inhibitory effects of propolis granular A P C on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice.

Sugimoto Y, Iba Y, Kayasuga R, Kirino Y, Nishiga M, Alejandra Hossen M, Okihara K, Sugimoto H, Yamada H, Kamei C.

Cancer Lett. 2003 Apr 25;193(2):155-9.

PMID:
12706872
29.

Ameliorative effects of histamine on 7-chlorokynurenic acid-induced spatial memory deficits in rats.

Nishiga M, Kamei C.

Psychopharmacology (Berl). 2003 Apr;166(4):360-5. Epub 2003 Feb 25.

PMID:
12601505
30.

Effects of second-generation histamine H1 receptor antagonists on the active avoidance response in rats.

Nishiga M, Fujii Y, Konishi M, Hossen MA; Chiaki Kamei.

Clin Exp Pharmacol Physiol. 2003 Jan-Feb;30(1-2):60-3.

PMID:
12542455
31.

Effects of NMDA antagonist MK-801 on radial maze performance in Zucker rats.

Nishiga M, Fujii Y, Sugimoto Y, Konishi M, Kamei C.

Brain Res. 2002 Sep 20;950(1-2):127-9.

PMID:
12231236
32.

Effect of docosahexaenoic acid-fortified Chlorella vulgaris strain CK22 on the radial maze performance in aged mice.

Sugimoto Y, Taga C, Nishiga M, Fujiwara M, Konishi F, Tanaka K, Kamei C.

Biol Pharm Bull. 2002 Aug;25(8):1090-2.

33.

Effects of the NMDA antagonist MK-801 on radial maze performance in histidine-deficient rats.

Nishiga M, Sugimoto Y, Taga C, Fujii Y, Kamei C.

Life Sci. 2002 Mar 22;70(18):2199-208.

PMID:
12002811
34.

Effects of histidine on working memory deficits induced by the 5-HT1A-receptor agonist 8-OH-DPAT.

Isayama S, Sugimoto Y, Nishiga M, Kamei C.

Jpn J Pharmacol. 2001 Aug;86(4):451-3.

35.

Effects of vasopressin on histamine H(1) receptor antagonist-induced spatial memory deficits in rats.

Taga C, Sugimoto Y, Nishiga M, Fujii Y, Kamei C.

Eur J Pharmacol. 2001 Jul 6;423(2-3):167-70.

PMID:
11448481

Supplemental Content

Loading ...
Support Center